http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102069686-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-204 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 |
| filingDate | 2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102069686-B1 |
| titleOfInvention | Pharmaceutical composition comprising bombysis corpus extract for treating or preventing colitis |
| abstract | The present invention relates to a composition for the prevention or treatment of colitis including baekpseum extract and health functional foods for the prevention or improvement of colitis. According to the present invention, the mule sleep extract was used to protect mucosal tissues, increase antioxidant enzyme activity, decrease serum IL-1β, IL-6, TNF-α cytokine concentration, decrease WBC count, neutrophil and lymphocyte count in colitis patients. Since it is possible to derive the effect of improving colitis, etc., it is expected to be useful in various related applications because it is implemented as a natural product-based pharmaceutical composition and auxiliary products for treating and improving colitis. |
| priorityDate | 2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 450.